Inflammatory proteins activate platelets, which have been observed to be directly related to
cancer progression and development. The aim of this systematic review is to investigate the …

Platelets have been recognized as key players in hemostasis, thrombosis, and cancer.
Preclinical and clinical researches evidenced that tumorigenesis and metastasis can be …

Transcriptome analysis of circulating tumor cells (CTCs), which migrate into blood vessels
from primary tumor tissues, at the single-cell level offers critical insights into the biology of …

Background Lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) are
the two most common subtypes of lung cancer. Previously, they were categorized into one …

Background The inflammatory response is extremely important in tumor progression, and it
is very difficult to identify prognostic indicators for neoadjuvant therapy in breast cancer …

Cancer is still a leading cause of death worldwide and liquid biopsy is a powerful tool that
can be applied to different stages of cancer screening and treatment. However, as the …

Liquid biopsy, a powerful non-invasive test, has been widely used in cancer diagnosis and
treatment. Platelets, the second most abundant cells in peripheral blood, are becoming one …

Antimetabolites, especially 5-fluorouracil, are commonly used clinically to treat breast, colon,
and other cancers. However, their side effects and inefficiency in monotherapy have …

Localized chemotherapy is emerging as a potential strategy for cancer treatment due to its
low systemic toxicity. However, the immune evasion of tumor cells and the lack of an …

Platelets are involved in tumor angiogenesis and cancer progression. Previous studies
indicated that cancer could affect platelet content. In the current study, we investigated …